| Financial Year |
March 31 2023 |
| Monetary Funds |
769,051,793.53 |
| Held-for-trading Financial Assets |
1,644,876,649.66 |
| Notes Receivable |
152,507,800.41 |
| Accounts Receivable |
702,740,873.22 |
| Advances to Suppliers |
111,013,500.64 |
| Other Receivables |
89,642,443.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,279,968,680.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,986,937.57 |
| Total Current Assets |
4,761,788,679.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
116,130.40 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
960,928,699.29 |
| Under-construction Projects |
29,692,483.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
1,110,636.39 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
260,011,772.65 |
| R&D expenses |
195,832,937.36 |
| Goodwill |
40,239,614.18 |
| Long-Term Deferred and Prepaid Expenses |
9,160,909.74 |
| Deferred Income Tax Assets |
18,511,340.80 |
| Other Non-Current Assets |
82,855,917.60 |
| Sub-Total of Non-Current Assets |
1,669,340,325.09 |
| Total Assets |
6,431,129,004.09 |
| Short-Term Loans |
20,016,666.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,322,158.47 |
| Accounts Payable |
523,473,303.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,632,671.94 |
| Taxes Payable |
37,432,033.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
341,308,022.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
314,323.14 |
| Other Current Liabilities |
15,260,462.22 |
| Sub-Total of Current Liabilities |
1,089,781,293.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
74,715,173.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
118,948,410.71 |
| Total Liabilities |
1,208,729,704.04 |
| Paid-In Capital(Or Share Stock) |
1,027,494,660.00 |
| Capital Surplus |
3,762,314,237.72 |
| Surplus Reserve |
481,346,118.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-16,000,960.16 |
| Minority Stockholder's Interest |
-31,370,520.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,253,769,820.10 |
| Owner's Equity（Stockholder's Equity） |
5,222,399,300.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,431,129,004.09 |
